U.S. Government-Backed MP Materials Stock Is Down 42% From Its 52-Week High. Is It Time to Buy the Dip?

MP Materials posted a sharp first-quarter inflection, with NdPr production up 63% year over year to a record 917 metric tons, sales up 49% to $90.6 million, and adjusted EBITDA improving to $36.6 million from a $2.7 billion loss. The company also benefits from a 10-year DoD magnet offtake commitment and a $110/kg NdPr price floor, while it builds a $1.25 billion Texas campus aimed at producing about 10,000 metric tons of magnets annually starting in 2028. Analysts expect non-GAAP EPS of $0.23 this year, rising to $1.10 in 2027 and $1.68 in 2028.

Analysis

The market is still valuing MP as if it were a cyclical commodity miner, but the strategic setup has shifted toward a quasi-regulated domestic industrial platform. The DoD backstop changes the left tail: pricing power is now partially policy-enforced, which should compress the volatility of cash flows and justify a materially higher multiple than legacy rare-earth peers. The second-order winner is not just MP — it is any end-user that can qualify for secure domestic inputs, because supply assurance becomes part of procurement value, especially in defense and industrial automation.

The key mispricing is timing. Investors are likely extrapolating the 2028 buildout as if it were far away, but the equity can re-rate well before first magnet production if quarterly EBITDA continues to inflect and the market starts discounting a credible domestic monopoly in a strategic input. The real catalyst sequence is: sustained NdPr output, evidence that the pricing floor is monetizing, then capex de-risking for the Texas campus. If any of those steps stalls, the stock will trade back to a commodity lens quickly.

The main risk is that the bullish narrative becomes too dependent on policy permanence and execution perfection. A change in administration, procurement priorities, or industrial policy could weaken the implied floor, while the 10X campus introduces classic ramp risk: cost overruns, delayed commissioning, and working-capital drag. There is also a hidden demand risk: if magnet end-markets soften over the next 12-18 months, MP may still be structurally advantaged, but the near-term earnings uplift can stall even with policy support.

Consensus seems to be underestimating how rare this is as an investable domestic monopoly, but overestimating how smooth the path to normalization will be. The stock is likely more attractive on pullbacks tied to capex anxiety than on momentum spikes, because the thesis is about multi-year option value, not a clean near-term earnings comp. In short: the strategic floor is real, but the equity still needs quarterly proof that the floor is converting into durable free cash flow.

Key Decisions for Investors

• Long MP on weakness over the next 1-3 weeks; target a 6-12 month horizon where policy-backed EBITDA visibility should drive multiple expansion. Use a staggered entry because the stock remains execution-sensitive around capex milestones.
• Buy MP 2026/2027 call spreads rather than outright calls to capture re-rating while limiting downside to a delayed Texas ramp; best risk/reward if implied volatility stays elevated after the recent move.
• Pair trade: long MP / short a basket of cyclical materials names with no policy backstop over a 3-6 month horizon. The spread should benefit if investors keep rewarding strategic supply-chain assets with lower earnings volatility.
• Trim or hedge if MP fails to show continued quarterly NdPr and EBITDA improvement over the next 1-2 earnings prints; that would suggest the market is moving from strategic premium back to commodity skepticism.
• For more conservative exposure, express the thesis through defense supply-chain beneficiaries rather than the miner itself, but only if they have explicit domestic sourcing leverage; MP remains the cleanest pure-play on the policy theme.